Long-term culture-initiating cells (LTC-IC) are hematopoietic progenitors able t o generate colony-forming unit-cells (CFU) after 5 t o 8 weeks (35 t o 60 days) of culture on bone marrow (BM) stroma and represent the most primitive progenitors currently detectable in vitro. We have recently reported that long-term cultures initiated with CD34'CD38-cells from BM or cord blood are able t o continue generating CFU for at least 100 days, ie, beyond the standard LTC-IC period. In this report, single-cell cultures from cord blood and retroviral marking of cord blood end BM were used t o study whether the subpopulation of CD34'CD38-cells able t o generate CFU beyond 60 days ("extended long-term culture-initiating cells" or ELTC-IC) are functionally distinct from LTC-IC in terms of timing of initial clonal proliferation and generative capacity. All cord blood LTC-IC formed clones of greater than HE CONCEPT of a functional hierarchy of "hemato-T poietic stem cells" based on their ability to provide short-or long-term hematopoietic reconstitution has been developed from a variety of murine transplant models.' * More recently, human clinical gene therapy trials using retroviral vectors to mark CD34+ hematopoietic progenitors have also demonstrated a dichotomy between the progenitor populations which produce early and late engraftment. Although retroviral marking can be shown during early engraftment, a decrease in the frequency of retroviral marked cells occurs over time, indicating that long-term repopulating cells are transduced less efficiently.'.'' It is likely that the major obstacle to efficient retroviral transduction of longterm repopulating stem cells is the quiescence and relative nonresponsiveness of these more primitive progenitors to the cytokines commonly used for retroviral gene transduction protocols.".12
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The standard in vitro assays of human hematopoiesis, the colony-forming unit-cell (CFU-C) and long-term culture-initiating cell (LTC-IC) assays, measure myeloid colony formation after 14 days and 5 to 8 weeks of culture, respecti~ely.",'~ Transduction of CFU-C and LTC-IC using 50 cells by day 30. In contrast, cord blood ELTC-IC proliferated later in culture, 50% forming clones after day 30. Although efficient retroviral marking of LTC-IC was seen (25% t o 4596). marking of ELTC-IC was inefficient (<I%), consistent with a more quiescent progenitor population. There was a positive correlation between time of clonal proliferation and generative capacity. ELTC-IC generated threefold t o fourfold more progeny than did LTC-IC ( P < .002). These studies show that there is a functional hierarchy of progenitors in long-term culture which correlates with their level of quiescence. By extending the LTC-IC assay, a more primitive progenitor may be studied that may be functionally closer t o the human long-term repopulating stem cell in vivo.
0 1996 by The American Society of Hematology. retroviral vectors is relatively efficient (20% to 60%), consistent with reports that a high percentage of both progenitor types are either cycling in vivo, or can be recruited into cell cycle within 72 hours of growth-factor tim mu la ti on.'^-^^ The lack of correlation of the levels of transduction seen in CFU-C and LTC-IC with those seen in long-term clinical genemarking studies demonstrates that the in vitro progenitor assays currently available measure functionally different, and presumably less quiescent, populations than the longterm repopulating stem cell.
We have previously reported that a population of progenitors within the CD34TD38-cells of bone marrow (BM) and cord blood have the ability to produce CFU from "extended long-term cultures" (ie, beyond the 35 to 60 days of the standard LTC-IC). 24 Cultures initiated with multiple CD34+CD38-cells give rise to two peaks of CFU production, the first during days 35 to 60 (the LTC-IC period) and the second between days 60 and 100 (the ELTC-IC period). 24 In this report we used single-cell cultures and retroviral marking of CD34TD38-cells to determine whether the two waves of CFU production seen in bulk CD34'CD38~-cultures arise from two functionally different progenitor subpopulations or, alternatively, represent prolonged CFU production from a common progenitor population. Our data demonstrate a functional hierarchy of progenitors in which those cells that proliferate later in culture are more primitive functionally and more resistant to retroviral transduction.
MATERIALS AND METHODS
Cell sources and isolation. BM samples were obtained by aspirating 10 to 20 mL of BM from the posterior iliac crests of normal healthy adult donors after obtaining informed consent under guidelines issued by the Committee for Clinical Investigation (CCVIRB) at Childrens Hospital Los Angeles. Umbilical cord blood was obtained after deliveries at Kaiser Permanente Hospital Sunset (Los Angeles, CA) by clamping the cord and allowing drainage of blood into containers prepared with the anticoagulant citrate-phosphatedextrose (Sigma, St Louis, MO). BM and cord blood samples were processed within 24 hours of collection.
Mononuclear cells from fresh cord blood and BM were isolated using density centrifugation with Ficoll-Hypaque (Pharmacia, Pisca- Fluorescence-activated cell sorting (FACS) was performed on a FACSVantage (BDIS) using Lysys I1 software (BDIS). Low-density, small to medium sized mononuclear cells were gated using forward and side scatter profiles, previously described as the "lymphoid region."z4 Isotype controls were used to set quadrant markers such that the quadrant defining negative PE and FITC fluorescence contained at least 97% of the isotype control cells from the lymphoid region. CD34TD38-cells were defined as those with high CD34 expression and anti-CD38 PE fluorescence less than half the maximum PE fluorescence of the isotype control. [IL-3],50 U/mL IL-6 and 50 ng/mL Steel factor [Sg). The establishment of stromal layers has been previously described.24 Every 3 to 4 weeks, nonadherent cells were removed from the cultures, counted, and aliquots replated in methylcellulose medium (1.3% methylcellulose in LTBMC medium with IL-3, IL-6, SF, and 50 ng/mL granulocyte-macrophage colony-stimulating factor [GM-CSF] and 2 U/mL erythropoietin). CFU were counted after 14 days in methylcellulose culture. Nonadherent cells not plated in methylcellulose were retumed to the original long-term culture. Nonadherent and adherent cells were replated on new irradiated stroma approximately every 4 weeks and cultures were fed twice weekly with half-medium changes.
All transduction experiments used the LN vector that contains the neomycin phosphotransferase (neoR) gene transcribed from the Moloney murine leukemia virus LTR promoter. Supematant containing LN was obtained from a high-titer packaging clone of the murine PA317 fibroblast cell line, LNcll (obtained from Dusty Miller, Fred Hutchinson Cancer Institute, Seattle, WA) grown to confluence at 37°C. Hematopoietic cells were incubated with filtered (0.45 pm) LN supematant and 4 pglmL of polybrene (Sigma).
To determine the timing of clonal proliferation of individual cells, single CD34+CD38-cord blood cells were plated in each well of a 96-well plate by FACS using the Automated Cell Deposition Unit (ACDU) device on the FACSVantage cell sorter (BDIS). Cells were grown on stroma in IL-3, IL-6, and SF and wells observed every 7 days for the first appearance of clonal proliferation (at least 50 cells per well can be visualized in stromal coculture as a cobblestone area). Representative clones were serially assayed to measure the number of cells produced and the CFU content (by replating aliquots of each clone in methylcellulose) over time for the life of each clone.
In two separate experiments, single CD34+CD38-cells were plated as above on day 0, and transduced with the LN vector once
Retroviral transduction.
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daily on days 1-3. Clones produced were picked, lysed, and analyzed by polymerase chain reaction (PCR) for detection of neoR. In one experiment, aliquots of each clone were also replated at day 30 in methylcellulose and CFU picked individually after 14 days for PCR detection of neoR.
In the bulk transduction experiments, approximately 500 CD34TD38-cells were isolated by FACS and immediately prestimulated in IL-3, IL-6, and SF in the presence or absence of irradiated BM stroma in 96-well plates. After 24 hours of prestimulation, LN supematant and polybrene were added once to the prestimulation cultures. After a further 48 to 72 hours, all cells (nonadherent and adherent) were replated onto new stroma in fresh LTBMC medium with IL-3, IL-6, and SF (without virus) to continue culture for a total of approximately 100 days. Aliquots of nonadherent cells from these LTBMC were replated every 3 to 4 weeks in methylcellulose medium. CFU arising after 14 days in methylcellulose were picked individually, and lysed in preparation for PCR detection of the transduced neoR gene.
Individual CFU were placed into Eppendorf tubes containing 1 mL of PBS and incubated 1 hour to dissolve the methylcellulose. Samples were then centrifuged and the pellet lysed in whole cell extraction buffer and proteinase K (20 mg/ mL; GIBCO BRL) as previously described.25 Samples containing 20 to 500 cells were lysed in 10 to 20 pL whole-cell extraction buffer and 1 pL proteinase K. Samples of greater than 500 cells were lysed in 40 pL extraction buffer and 2 pL proteinase K. Positive controls used for presence of neoR were whole-cell lysates of the virus producer line LNcl 1. Each reaction used two negative controls to test for contamination: (1) and extension (2 minutes at 72°C). The following 35 cycles were conducted as the first except that denaturation was reduced to 2 minutes, and the final cycle had a 10-minute extension step. After PCR amplification, samples were electrophoresed in 1.5% agarose and 1.5% NuSieve GTG agarose (FMC Bioproducts, Rockland, ME). The gel was stained with ethidium bromide, transferred to a nylon membrane, and probed with a neoR specific probe radiolabeled with P-32 to improve sensitivity of detection of the transgene in small cell samples.
Analysis of correlations was performed using the Spearman Test (a nonparametric analysis). Significant differences between grouped data were analyzed using Fisher's Exact Test (for gene transfer data) or Wilcoxon Rank Test (for data on generative capacity).
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Statistical analysis. over time. Cells were defined as LTC-IC or ELTC-IC based on the time point of stromal coculture at which they last produced CFU, irrespective of onset of clonal proliferation or onset of CFU production. LTC-IC were defined as single cells that generated CFU beyond day 35 but not beyond day 60. ELTC-IC were defined as single cells which generated CFU beyond day 60. A total of 2,529 cord blood CD34TD38-cells were plated as single cells per well over six independent experiments, 10.9% of which were LTC-IC and 2.9% ELTC-IC. Most (74.1%) of the CD34TD38-cells never formed visible clones during 100 days of culture. Of the 25.9% which did proliferate, the majority (92.5%) formed clones by day 30. Thus, 7.5% (or 1.9% of all CD34TD38-cells) formed clones after day 30 (Fig 1) . Figure 2 summarizes data from 123 individual CD34+ CD38-cord blood cells analyzed which were able to generate CFU at some point during the 100 days of stromal coculture. Timing of CFU production correlated with timing of proliferation ( r = .69, P < .OOOOOl). Cells that proliferated early in culture (before day 30) infrequently continued to generate CFU late in culture (after day 60). All LTC-IC had formed clones by day 30, most between day 21 and day 30. In contrast, ELTC-IC (ie, cells generating CFU after 60 days of stromal coculture) arose mainly from ''late proliferating cells," ie, those that first formed clones after day 30. Thus, CFU produced in the ELTC-IC period did not simply represent a continued output of progeny from LTC-IC. ELTC-IC are CD34TD38-cells with either a later onset of proliferation andor a slower rate of cell division than LTC-IC. There was some overlap in the timing of proliferation between the LTC-IC and ELTC-IC populations; approximately 5% of early proliferating cells were ELTC-IC. However, all late proliferating cells were ELTC-IC ie if cells produced clones after 30 days they were always able to generate CFU beyond 60 days.
RESULTS

ELTC-IC
Late proliferating cells have a greater generative capaci9 than early proliferating cells. To compare the generative capacity of early and late proliferating cells, clones were removed from each stromal culture every 3 to 4 weeks and aliquots taken to measure the number of total progeny and CFU produced from each CD34TD38-cell over time. After counting, the residual cells were then replated into the original wells to continue culture. Figure 3 shows the total number of cells present in each clone at the time of maximum clonal size, grouped according to the day on which clones first appeared. There was a positive correlation of cell number with the day of clonal appearance ( r = .59, P < .OOOOOI).
Late proliferating cells (after 30 days) produced clones with significantly more cells (approximately fourfold more) than those which appeared early (before 30 days) ( P < .0003).
The rare clones that appeared after 60 days (0.22% of all CD34TD38-cells) gave rise to approximately IO-fold more progeny than early proliferating cells producing a mean 9.9 X IO6 progeny per single CD34'CD38-cell. Thus, late proliferating cells have a significantly higher generative capacity than do early proliferating cells.
The generation of CFU from CD34TD38-cells was measured by replating aliquots of cells from each clone into methylcellulose between one and seven times during the life of the clone. Onset of clonal growth correlated with the likelihood that a clone would produce CFU at least once during the replating (Fig 4) . Seventy percent of all early proliferating clones produced CFU whereas 100% of late appearing clones produced CFU.
Only 44.4% of early proliferating cells were LTC-IC (ie, 49.4% of early proliferating cells either did not generate CFU or ceased to generate CFU before day 35). By exclud- Transduction levels of late proliferating cells are lower than early proliferating cells. Within the constraints of our clonal assay it is possible only to note when a clone of 50 cells (signifying approximately six cell divisions) has appeared. Clones may appear late because of a delay in the onset of cell division and/or a slower rate of cell cycling during the first few divisions. To test whether onset of cell division was synchronous in early and late proliferating cells, a retroviral vector was used to mark dividing cells. Single CD34TD38-cells were plated in each well of 96-well plates and transduced by daily additions of the LN vector (containing the marker gene neo') on days 1-3. After 30 days, nonadherent cells from each visible clone were picked and lysed for PCR detection of the transgene neo'. Thus, the proportion of CD34TD38-cells with any progeny marked by retrovirus was determined. A high frequency (17.6% to 77.4%) of early proliferating clones contained the neo' gene in detectable levels (Table I) . To quantitate the percentage of progeny from each clone which was marked with neo', in one experiment aliquots of each clone were also replated in methylcellulose and the CFU produced were picked and analyzed individually by PCR. As murine leukemia retroviruses can integrate only into postreplication DNA, no more than 50% of the progeny from each target cell should be marked."." The frequency of CFU transduced * PCR detection of neoR was performed on nonadherent cells of clones grown from single CD34+CD38-cells. Shown is the percentage of clones with detectable levels of neoR, ie the percentage of proliferating CD34TD38-cells which had any progeny marked. As PCR was not quantitative, the proportion of progeny from each CD34'CD38-cell is not determined from this data.
t In expt no. 1, early proliferating cells from single CD34TD38-cells were also replated into methylcellulose at day 35. PCR on individual CFU was performed to determine the percentage of progeny in each neoR positive clone which was marked. 33.9% lr 8.9% CFU (mean from each clone was high (33.9% 2 8.9%, mean 2 SEM), confirming highly efficient transduction of CD34TD38-cells which proliferate early in culture. Thus, a high percentage of early proliferating cells must undergo at least one cell division within the 3-day period of transduction.
In contrast, when PCR analysis of late appearing clones was performed at day 60, the transgene was undetectable in all 10 clones (Table I) . It is likely that the lack of retroviral marking in clones that appear after day 30 is because the first cell division occurs after the transduction period.
Transduction levels qf ELTC-IC are lower than LTC-IC. As retroviral vectors stably integrate into target cell genomes, retroviral marking can be used to track the sustained presence of progeny from the same transduced parent cell. Retroviral marking of CFU produced at different time points For personal use only. on October 23, 2017. by guest www.bloodjournal.org From from long-term bulk cultures of BM and cord blood CD34+CD38-cells was studied to determine if transduction levels of ELTC-IC were lower than LTC-IC as expected from the single-cell transduction experiments.
CD34TD38-cells (approximately 500 cells/well) from BM or cord blood were isolated by FACS and plated into LTBMC medium on day 0 as described in Materials and Methods. On day 1, supernatant containing the LN retroviral vector was added to the cultures with polybrene. After 3 days' incubation in virus, cells were removed from the transduction culture, washed and replated onto new stroma in fresh LTBMC medium and cultured for at least 100 days. Aliquots of nonadherent cells were removed every 3 to 4 weeks and replated into methylcellulose medium to assay the presence of CFU. After 14 days of methylcellulose culture, CFU were individually picked and PCR performed to detect the frequency of the marker gene neoR in the CFU arising at each period of stromal coculture.
Retroviral marking of the CFU produced during the LTC-IC period was relatively efficient, ranging from 25% to 40% (Fig 5, Table 2 ), consistent with previous No conclusions regarding intrinsic differences between BM and cord blood LTC-IC in cell cycling or efficiency of transduction can be made from this data. Cord blood and BM samples were not transduced simultaneously within the same experiment, and the wide sample to sample variation seen in progenitor transduction protocols could account for the lower transduction of cord blood LTC-IC shown in Table 2 . However, the relationship of different transduction levels between progenitor groups within each experiment was consistently seen. Marking of 5-week LTC-IC was more slightly more efficient than that of 8-week LTC-IC. In contrast. the fre- Transduction efficiency of LTC-IC and ELTC-IC was determined using PCR detection of the marker gene neoR in individual CFU produced during either the LTC-IC period (35-60 days) or ELTC-IC period (after 60 days) of long-term culture. Data are presented graphically in Fig  5. * LTC-IC transduction was significantly less than ELTC-IC transduction levels in each experiment ( P < .00005, using Fisher's Exact test with two-tailed alternative).
quency of transduced CFU produced after 60 days decreased sharply, with all cultures (BM and cord blood) eventually reaching undetectable levels ( P < .00005 for significant difference between transduction of LTC-IC and ELTC-IC). The almost complete absence of retroviral marking of ELTC-IC and relatively efficient marking of LTC-IC within each experimental sample is further evidence that the two subpopulations of CD34TD38-cells are functionally distinct and supports the hypothesis that ELTC-IC are a more quiescent cell population which does not divide during the first 3 days in culture.
DISCUSSION
CD34TD38-cells comprise approximately 0.02% of the mononuclear cells of BM and cord blood, lack immunophenotypic evidence of lineage commitment, and exist almost exclusively in GO/Gl status when in v~v o .~~,~~. " However, despite the immunophenotypic uniformity within the CD34+CD38-population, significant functional heterogeneity exists. We have described a functional hierarchy within the CD34'CD38-progenitor population that is based on timing of cell proliferation and of clonogenicity in longterm culture. Onset of proliferation from CD34'CD38-cells occurs mainly during the first 30 days of stromal coculture and growth factor stimulation. All LTC-IC are contained within these early proliferating cells. In addition to LTC-IC, cells that proliferate but do not generate CFU and cells that cease to produce CFU by day 35 are contained within the early proliferating cell population (Fig 6) . A smaller subpopulation of CD34+CD38-cells proliferate later, taking more than 30 days to complete the first five to six cell divisions. These late proliferating cells are able to produce CFU for over 60 days of stromal culture and have been designated ELTC-IC. Late proliferating cells have a greater generative capacity and clonogenicity than early proliferating cells, suggesting they are a more functionally primitive subpopulation.
The correlation between the onset of proliferation and generative capacity exists throughout the period of stromal coculture, demonstrating a functional hierarchy within each of the LTC-IC and ELTC-IC populations. Functional overlap also exists between subsets of LTC-IC and ELTC-IC (Fig  6) . Petzer et aI3" have recently reported that approximately 20% of LTC-IC (or 2% of BM CD34'CDW cells) are capable of self-renewing divisions during 6 weeks culture on murine fibroblasts engineered to secrete human SF, IL-3, and G-CSF. The timing of onset of clonal proliferation from these "self-renewing LTC-IC" grown on stroma was not specifically determined, but must have occurred during the first 6 weeks of culture. In our own studies with the ELTC-IC assay (which uses a similar growth factor combination to the study by Petzer et al) a small percentage of early proliferating cells (approximately 1 .S% of all CD34'CD38-cells) continue to produce CFU beyond 60 days and have thus been defined as ELTC-IC. It is possible that these "early proliferating ELTC-IC" and the "self-renewing LTC-IC" described by Petzer et al are very similar populations of cells. In addition, some cells that produced CFU at 12 weeks but not at 6 weeks were noted by Petzer et a1 and are presumably a similar population to the late proliferating ELTC-IC reported here. Thus, although ELTC-IC have been defined to contrast them with LTC-IC, it is more accurate to consider the CD34TD38-population as a functional continuum rather than as discrete subgroups. The clearest distinctions between the progenitor types are seen at the latest time points of the assay, ie, all late proliferating cells are ELTC-IC and these cells have significantly greater generative capacity than early proliferating cells. It is evident that by extending longterm culture beyond the standard 5 to 8 weeks, a significantly more primitive and quiescent population is revealed than is usually measured by in vitro assays of hematopoietic stem cells.
The designation of early and late proliferating cells is based on the time at which clones of approximately SO cells are first observed. Using this assay, it is not possible to determine whether late proliferating cells are those with a delay in the onset of the first cell division or, alternatively, are those with slower cycling times. The finding that lateproliferating cells (and ELTC-IC) are not transduced with a retroviral vector during the first 3 days of culture, in contrast to the efficient transduction of early proliferating cells (and LTC-IC), argues that the onset of cell division is delayed in ELTC-IC relative to LTC-IC. Transductions over longer culture periods will more closely define for how long ELTC-IC remain quiescent in vitro.
The majority of CD34TD38-cells do not form clones at any point during 100 days of growth-factor stimulation. The status of these nonproliferating cells is as yet unknown, but it is likely they comprise both cells whose viability is not maintained in culture and cells which are maintained but are nonresponsive to the cytokine combinations used. We have recently reported that the cytokine FLT3 ligand (FL) significantly increases the percentage of CD34TD38-cells which form clones at both early and late time points, suggesting a role for FL in maintaining primitive progenitors in vitro.3' The feature of FL which most distinguished it from other early acting cytokines such as IL-3, IL-6, and SF, was its enhancement of CFU output during the ELTC-IC phase of long-term culture. The finding that these cytokines act differentially on LTC-IC and ELTC-IC is further evidence that the timing of proliferation and the duration of CFU production can be used to define functionally different populations within the CD34TD38-population.
The length of time single-cell cultures were continued in this report and in the FL studies was limited mainly by technical issues, eg, maintaining the viability of the stromal layer. It is possible that by extending the single-cell longterm cultures beyond 100 days, clones from viable cells would continue to appear. The possibility that some CD34TD38-cells may initiate cell division after remaining For personal use only. on October 23, 2017. by guest www.bloodjournal.org From quiescent for many weeks despite continuous exposure to stimulatory growth factors, suggests that, although early proliferating cells are responsive to cytokine stimulation, lateappearing cells initiate division in a more random and independent fashion suggestive of the clonal succession of stem cells seen in animal model^.'^-^^ Cells that contribute to long-and short-term repopulation in murine transplant models can be identified and separated using a variety of parameters including cell size, immunophenotype, and staining with rh~damine.~-'*'.'~ Based on differences in sensitivity to 5-fluorouracil (5-FU), most shortterm repopulating cells are believed to be in cell cycle and have limited potential for self
In contrast, longterm murine repopulating cells are in a quiescent (GO) phase and possess great generative capacity and the potential for self r e n e~a l . '~*~~ However, two animal models (one canine transplant model and the other studying human CD34' cells transplanted into immunodeficient mice) suggest that transplantation of transduced progenitors can result in relatively long-term survival of these activated ~ells.'~~'' Bienzle et al" reported that unpurified canine BM can be transduced with retroviral vectors during the first 21 days of long-term culture in the absence of additional growth factors, and contribute to long-term hematopoiesis in vivo. This report and the report by Nolta et ai3' suggests that cycling (and transduced) progenitors can contribute to in vivo hematopoiesis, for at least the first 12 months. Nevertheless, in the majority of dogs studied by Bienzle et al, gene transfer fell significantly after 12 months suggesting more quiescent, nontransduced progenitors began to contribute to hematopoeisis at later time points. In the ELTC-IC assay, continuous exposure to high concentrations of stimulatory growth factors in vitro presumably more rapidly drives progenitors to terminal differentiation once cycling is induced. Berardi et al," using 5-FU treatment, have identified a highly primitive population of human progenitors which remain quiescent after 7 days of in vitro cytokine stimulation. The late-proliferating cells described in our report similarly represent an in vitro assay of quiescent and relatively cytokine nonresponsive primitive human hematopoietic progenitors.
Based on the results of human clinical gene therapy trials and most large animal models, the efficiency of transducing long-lived repopulating stem cells with retroviral vectors appears to be less than I % with current ex vivo transduction protocols.9~'0~38~'~ However, the same protocols result in transduction of approximately 20% to 60% of CFU and LTC-IC, suggesting that these in vitro assays are measuring progenitors that divide rapidly ex vivo and do not reflect events in the long-term repopulating stem cell p 0 0 1 .~~~~'~~'~~~ Cell-cycling assays using tridiated thymidine suicide also suggest that a high proportion of LTC-IC are in cell cycle in vivo and are rapidly recruited into cell cycle with growth factor stimulation." The ELTC-IC assay, based as it is on the quiescence of a functionally primitive progenitor subpopulation, may more closely reflect events in the long-lived repopulating stem cell and may prove a more useful tool for the development of effective stem cell transduction protocols.
